Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-24 Sale |
2023-08-25 5:03 pm |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
14,386 | $20.3 | $292,036 | 335,477 (Direct) |
View |
| 2023-08-24 Sale |
2023-08-25 5:00 pm |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer |
12,333 | $20.3 | $250,360 | 416,260 (Direct) |
View |
| 2023-08-24 Sale |
2023-08-25 4:57 pm |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
12,333 | $20.3 | $250,360 | 337,392 (Direct) |
View |
| 2023-08-14 Sale |
2023-08-16 4:11 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
103,058 | $21.42 | $2,207,178 | 1,026,739 (Direct) |
View |
| 2023-08-07 Sale |
2023-08-08 4:44 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
101,339 | $21.73 | $2,202,096 | 1,129,797 (Direct) |
View |
| 2023-07-26 Sale |
2023-07-27 4:33 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
3,917 | $21.63 | $84,725 | 326,774 (Direct) |
View |
| 2023-07-19 Sale |
2023-07-20 4:37 pm |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
426 | $24.94 | $10,624 | 349,725 (Direct) |
View |
| 2023-07-19 Sale |
2023-07-20 4:35 pm |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
2,725 | $24.94 | $67,962 | 349,863 (Direct) |
View |
| 2023-07-12 Sale |
2023-07-13 5:11 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
3,233 | $19.73 | $63,787 | 1,231,136 (Direct) |
View |
| 2023-07-12 Sale |
2023-07-13 5:10 pm |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer |
1,470 | $19.73 | $29,003 | 428,593 (Direct) |
View |
| 2023-04-25 Sale |
2023-04-26 4:12 pm |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
509 | $16.29 | $8,292 | 350,151 (Direct) |
View |
| 2023-04-25 Sale |
2023-04-26 4:08 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
2,633 | $16.29 | $42,892 | 330,691 (Direct) |
View |
| 2023-04-18 Sale |
2023-04-19 4:15 pm |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
3,423 | $15.27 | $52,269 | 352,588 (Direct) |
View |
| 2023-04-18 Sale |
2023-04-19 4:12 pm |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer |
1,544 | $15.27 | $23,577 | 430,063 (Direct) |
View |
| 2023-04-18 Sale |
2023-04-19 4:09 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
3,395 | $15.27 | $51,842 | 1,234,369 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-03 07:24 am |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
537 | $18.24 | $9,795 | 262,996 (Direct) |
View |
| 2023-01-26 Sale |
2023-01-27 07:20 am |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
10,156 | $18.51 | $187,988 | 245,660 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-13 08:21 am |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
4,021 | $16.8 | $67,553 | 993,932 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-13 08:19 am |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
60,490 | $16.79 | $1,015,596 | 331,419 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-13 08:16 am |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
4,510 | $16.75 | $75,525 | 268,347 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-13 08:13 am |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
44,568 | $16.75 | $746,317 | 263,533 (Direct) |
View |
| 2022-10-21 Sale |
2022-10-25 07:43 am |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
341 | $9.67 | $3,297 | 308,101 (Direct) |
View |
| 2022-10-13 Sale |
2022-10-17 08:59 am |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
928 | $9.18 | $8,519 | 391,909 (Direct) |
View |
| 2022-10-13 Sale |
2022-10-17 08:57 am |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
2,793 | $9.18 | $25,640 | 997,953 (Direct) |
View |
| 2022-10-11 Sale |
2022-10-13 4:20 pm |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
12,500 | $9.44 | $118,000 | 272,857 (Direct) |
View |
| 2022-10-06 Purchase |
2022-10-07 4:32 pm |
Immunovant Inc. | IMVT | Roivant Sciences Ltd. 10% Owner |
416,667 | $6 | $2,500,002 | 73,805,331 (Direct) |
View |
| 2022-09-30 Purchase |
2022-10-04 4:27 pm |
Immunovant Inc. | IMVT | Pande Atul Director |
15,000 | $5.6 | $84,000 | 102,985 (Indirect Direct) |
View |
| 2022-09-28 Sale |
2022-09-29 5:09 pm |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
535 | $4.67 | $2,498 | 392,837 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-04-17 Option Award |
2023-04-19 4:23 pm |
N/A 2033-04-17 |
Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:37 pm |
N/A 2033-04-12 |
Immunovant Inc. | IMVT | Pande Atul Director |
28,783 | $0 | 131,768 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:35 pm |
N/A 2033-04-12 |
Immunovant Inc. | IMVT | Hughes Douglas J. Director |
28,783 | $0 | 130,015 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:33 pm |
N/A 2033-04-12 |
Immunovant Inc. | IMVT | Fromkin Andrew J. Director |
28,783 | $0 | 117,268 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:31 pm |
N/A 2033-04-12 |
Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director |
28,783 | $0 | 138,768 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:29 pm |
N/A 2033-04-12 |
Immunovant Inc. | IMVT | Torti Frank Director |
280,208 | $0 | 673,566 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:26 pm |
N/A 2033-04-12 |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
230,269 | $0 | 561,688 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:24 pm |
N/A 2033-04-12 |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
201,485 | $0 | 447,145 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:22 pm |
N/A 2033-04-12 |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
201,485 | $0 | 469,832 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:19 pm |
N/A 2033-04-12 |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
201,485 | $0 | 464,481 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:14 pm |
N/A 2033-04-12 |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
560,417 | $0 | 1,554,349 (Direct) |
View |